Holdings
Velan Capital Investment Management LP
As of Sep 30, 2026, Velan Capital Investment Management LP reported 40 positions worth US$103M. Largest: Praxis Precision Medicines, Inc., Immix Biopharma, Inc. and Protara Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | 76,600 | US$22.3M | −12,181 | Sep 30, 2026 |
| Immix Biopharma, Inc. | 1.08M | US$11.3M | no change | Sep 30, 2026 |
| Protara Therapeutics, Inc. | 2.84M | US$8.68M | no change | Sep 30, 2026 |
| Sutro Biopharma, Inc. | 510K | US$8.22M | −2,122 | Sep 30, 2026 |
| Abivax SA | 65,630 | US$6.5M | no change | Sep 30, 2026 |
| MapLight Therapeutics, Inc. | 625K | US$6.37M | +132K | Sep 30, 2026 |
| Anteris Technologies Global Corp. | 700K | US$5.44M | no change | Sep 30, 2026 |
| Edesa Biotech, Inc. | 1.28M | US$5.4M | +455K | Sep 30, 2026 |
| Avalo Therapeutics, Inc. | 324K | US$4.97M | no change | Sep 30, 2026 |
| Xencor, Inc. | 175K | US$4.37M | −80,000 | Sep 30, 2026 |